Key Metrics of Akanda Corp.
Market cap$2.7MAKAN · $1.15
Competitors10identified
About Akanda Corp.
Sectors
Company details
- Founded
- 2022
- Listed
- Nasdaq: AKAN (since 2022)
Operational Areas of Akanda Corp.
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameAkanda Corp.
TickerAKAN
ExchangeNasdaq
CountryUnited Kingdom
SEC CIK0001888014
Listed since2022
Industry Medicinal Chemicals and Botanical Products
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—
US market & SEC filings
AKAN · Nasdaq · SEC CIK 0001888014
Last price · 24 Oct 2026
$1.15
+2.68%
Market cap$2.7M
P/E—
Volume3,089,065
SectorHealth Care Medicinal Chemicals and Botanical Products
Country · IPOUnited KingdomListed 2022
AKAN share price
Annual results (SEC EDGAR)
No annual results in SEC XBRL data for this company yet.
Vendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Akanda Corp.
Competitors10identified
Countries2most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of BIL Enterprises. | hospitalitybrandbook.com | — | United Kingdom | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.